Press Releases Archives - Page 81 of 103 - Lupin

BSE 2324.25 NSE 2324.50

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2324.25 NSE 2324.50

Lupin launches Generic Aciphex® Delayed-Release Tablets, 20 mg in the US

November 11, 2013

Lupin Receives International Sustainability Rating Standard (ISRS) Certification First Pharmaceutical Company globally to adopt ISRS, 8th Edition standard

October 18, 2013

Lupin launches Generic ZYMAXID™ Ophthalmic solution in the US

October 3, 2013

Lupin Expands US Pediatric Brands Portfolio Inks Strategic Agreement to Promote Locoid® Lotion to US Pediatricians

September 23, 2013

Lupin Receives FDA Approval for Generic Ambien CR® Extended-release Tablets

September 16, 2013

Lupin Receives FDA Approval for Generic Rifadin® Capsules

August 23, 2013

Lupin Expands Branded Play Announces Acquisition of Exclusive US Rights to Alinia® for Oral Suspension

Strong Margins, Robust Profitability Quarter I Results, FY 2013-14 EBITDA up 44%, Net profit up 43%

Lupin receives FDA Approval for Generic Ranexa® Extended-release Tablets

Lupin Receives Tentative FDA Approvals for Generic Nuvigil® Tablets and Generic Oracea® Capsules

1 2 … 80 81 82 … 102 103

Search

Hit enter to search or ESC to close